Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Richard C. Jordan"'
Autor:
Elisabeth A. Gebreegziabher, Catherine E. Oldenburg, Stephen C. Shiboski, Alan N. Baer, Richard C. Jordan, Jennifer R. Rose‐Nussbaumer, Vatinee Y. Bunya, Esen K. Akpek, Lindsey A. Criswell, Caroline H. Shiboski, Thomas M. Lietman, John A. Gonzales
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 3, Pp 231-237 (2022)
Objective The objective of this study was to examine the association of smoking with Primary Sjögren syndrome (pSS) classification and pSS diagnostic test results. We hypothesized that past and current smokers would have lower odds of being classifi
Externí odkaz:
https://doaj.org/article/2ecf2af38f53411c8c0e663dbe06e84a
Autor:
Chieko Michikawa, DDS, PhD, Pedro A. Torres-Saavedra, PhD, Natalie L. Silver, MD, MS, Paul M. Harari, MD, Merrill S. Kies, MD, David I. Rosenthal, MD, Quynh-Thu Le, MD, Richard C. Jordan, DDS, PhD, Dzifa Y. Duose, PhD, Saradhi Mallampati, DVM, PhD, Sanchit Trivedi, MS, Rajyalakshmi Luthra, PhD, Ignacio I. Wistuba, MD, Abdullah A. Osman, PhD, Olivier Lichtarge, MD, PhD, Robert L. Foote, MD, Upendra Parvathaneni, MBBS, D. Neil Hayes, MD, MPH, Curtis R. Pickering, PhD, Jeffrey N. Myers, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 100989- (2022)
Purpose: An evolutionary action scoring algorithm (EAp53) based on phylogenetic sequence variations stratifies patients with head and neck squamous cell carcinoma (HNSCC) bearing TP53 missense mutations as high-risk, associated with poor outcomes, or
Externí odkaz:
https://doaj.org/article/af4a399b5e144a18b46cb1524d746ef0
Autor:
Maura L. Gillison, Robert L. Ferris, Jonathan Harris, A. Dimitrios Colevas, Loren K. Mell, Christina Kong, Richard C. Jordan, Kevin L. Moore, Minh-Tam Truong, Claudia Kirsch, Arnab Chakravarti, Dukagjin M. Blakaj, David A. Clump, James P. Ohr, John F. Deeken, Michael F. Gensheimer, Nabil F. Saba, Jennifer A. Dorth, David I. Rosenthal, Rom S. Leidner, Randall J. Kimple, Mitchell Machtay, Walter J. Curran, Pedro Torres-Saavedra, Quynh Thu Le
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:847-860
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece44a5b88e2336bcee2b4fbd237a6ee
https://doi.org/10.1016/j.ijrobp.2022.10.008
https://doi.org/10.1016/j.ijrobp.2022.10.008
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Supplemental figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf00eaf2d9e40589c46c96429dee6cf
https://doi.org/10.1158/1078-0432.22466460.v1
https://doi.org/10.1158/1078-0432.22466460.v1
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Purpose: We previously demonstrated an association between decreased SMAD4 expression and cetuximab resistance in head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to further elucidate the clinical relevance of SMAD4 loss i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ea9a1c9d805e925aa082206b09928c
https://doi.org/10.1158/1078-0432.c.6526317
https://doi.org/10.1158/1078-0432.c.6526317
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Representative SMAD4 IHC, FaDu negative control, SCC25/SCC61 positive control.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24090d568f75d4ce7b2c2cc9a9ae52a3
https://doi.org/10.1158/1078-0432.22466463.v1
https://doi.org/10.1158/1078-0432.22466463.v1
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Matrigel colony formation assay of FaDu-mock and FaDu-SMAD4 cells treated with PBS or Cetuximab in combination with JNKi (SP600125) or MEKi (U0126) at indicated concentrations for 7 days. (*p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89bde50c65c1ffc652bae9e99ac1f98
https://doi.org/10.1158/1078-0432.22466448.v1
https://doi.org/10.1158/1078-0432.22466448.v1
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
(A) Western blot confirming the knockdown of SMAD4 levels by stable expression of short-hairpin RNA in SCC25 cell line. (SC: scrambled control shRNA, SMAD4KD: shRNA against SMAD4). (B) Matrigel colony formation assay was performed for SCC25 cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59dfc9b242a15df7cea0c27e96912937
https://doi.org/10.1158/1078-0432.22466454.v1
https://doi.org/10.1158/1078-0432.22466454.v1
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Western blot analysis of SCC61L-SC and SMAD4KD cells for phospho-SMAD2 and total SMAD2/3 expression levels. Actin was used as a loading control.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3199f5bc7293ede70954657b90a5120
https://doi.org/10.1158/1078-0432.22466457
https://doi.org/10.1158/1078-0432.22466457
Autor:
Christine H. Chung, David Sidransky, Harry Quon, Hyunseok Kang, Hao Wang, Richard C. Jordan, Christina S. Kong, Quynh-Thu Le, Jimena Perez, Rajani Ravi, Atul Bedi, Ana Markovic, Jason D. Howard, Elana J. Fertig, Alex Zhavoronkov, Eugene Makarev, Evgeny Izumchenko, Ruchira S. Ranaweera, Hiroyuki Ozawa
Supplemental Table 1. Summary of patient characteristics with newly diagnosed HNSCC. Supplemental Table 2. Summary of patient characteristics with recurrent and/or metastatic HNSCC. Supplemental Table 3. Injection of FaDu-SMAD4 cells results in lower
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8a0007ea7e4739453d86f91849b36e
https://doi.org/10.1158/1078-0432.22466445.v1
https://doi.org/10.1158/1078-0432.22466445.v1